TheEdgeResearch
Home / Stocks / EXD

Eaton Vance Tax-Managed Buy-Write Strategy Fund (EXD)

NYSE Financial Services Asset Management
$9.58 ▲ +0.08%
Market Cap
$93.6M
Sector
Financial Services
Industry
Asset Management
Beta
0.00
52-Wk Range
8.95-10.1
CEO
Payson F. Swaffield CFA
Country
US
Currency
USD

Eaton Vance Tax-Managed Buy-Write Strategy Fund operates in the Asset Management industry of the Financial Services sector, headquartered in Boston, MA, US. The stock last traded at $9.58, up 0.08% on the session, giving a market capitalisation of $93.6M. On trailing twelve-month figures it carries a trailing P/E of -4.44, a net margin of 100.8%. Its beta of 0.00 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-4.44
Price / Sales
-4.48
Price / Book
1.06
EV / EBITDA
0.00
Gross margin
100.0%
Operating margin
100.8%
Net margin
100.8%
Return on equity
Debt / equity
0.00
Current ratio
0.00
Dividend yield
8.9%
Payout ratio
0.0%
Company profile
Exchange
New York Stock Exchange
Employees
IPO date
2010-02-09
Headquarters
Boston, MA, US
About Eaton Vance Tax-Managed Buy-Write Strategy Fund

The Eaton Vance Tax-Managed Buy-Write Strategy Fund operates as a closed-end equity mutual fund, principally managed by Eaton Vance Management with co-management responsibilities also held by Parametric Risk Advisors, LLC. Its investment strategy focuses on equity markets, involving both direct investments in company stocks and the strategic use of derivatives like options. Portfolio construction is driven by rigorous internal and proprietary research. The fund measures its performance against the S&P 500 Composite Stock Price Index and the NASDAQ 100 Index. This U.S.-domiciled fund commenced operations on June 29, 2010.

Comparable companies

Eaton Vance Tax-Managed Buy-Write Strategy Fund is most often compared with the following Financial Services names:

CENDEXFMOFTEKXGDLHNWJEMDNKGRCMFXTTP
More research on EXD
EXD technical analysis EXD TheEdge Score Compare against peers
Open full interactive analysis & DCF →